Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

REVEALED: Solv | Rare Historical Photos

How Is Solventum's Stock Performance Compared to Other Healthcare Stocks

Despite lagging behind other healthcare stocks over the past year, analysts remain fairly optimistic about Solventum, supported by the stock's bullish momentum and rosy outlook.

Barchart · Sep 25

Are Wall Street Analysts Bullish on Solventum Stock?

Solventum has underperformed the broader market, while analysts remain moderately optimistic about its future prospects.

Barchart · Aug 14

Solventum Nears Inflection Point As It Begins to Unlock Value

Solventum shares gain on strong Q2 revenue, earnings, and cash flow, buybacks, and improved guidance, with analysts raising price targets amid a discounted valuation versus med/tech peers.

MarketBeat · Aug 7

From analysis to the latest developments in health,
read the most diverse news in one place.

Solventum’s Q2 2026 Earnings: What to Expect

Solventum is scheduled to report its fiscal second-quarter results early next month, with analysts expecting a modest year-over-year increase in earnings.

Barchart · Jul 22

Solventum Stock: Is SOLV Underperforming the Healthcare Sector?

The healthcare sector has had a mixed year, yet Solventum shareholders might feel as though they drew the short straw.

Barchart · Jun 22

What Are Wall Street Analysts' Target Price for Solventum Stock?

While Solventum has considerably underperformed the broader market over the past 52 weeks, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

Barchart · May 19

SOLV Energy Q1 Earnings Call Highlights

SOLV Energy (NASDAQ:MWH) reported sharply higher first-quarter revenue and adjusted earnings, raised its full-year profit outlook and said demand for solar, storage and grid infrastructure remains strong as U.S. power needs accelerate. On the company’s first-quarter 2026 earnings call, Chief Execut

MarketBeat · May 12

Read news from The Economist, FT, and more,
with one subscription

Solventum Earnings Preview: What to Expect

Solventum will release its first-quarter earnings next month, and analysts anticipate a marginal bottom-line growth.

Barchart · Apr 23

Solventum Stock: Is Wall Street Bullish or Bearish?

Solventum has lagged behind the broader market over the past year, and analysts remain somewhat optimistic about the stock’s prospects.

Barchart · Feb 11

What You Need To Know Ahead of Solventum Earnings Release

Solventum is expected to release its fiscal fourth-quarter earnings soon, and analysts project a modest earnings increase.

Barchart · Jan 22

Is Solventum Stock Outperforming the Nasdaq?

Solventum has delivered stronger performance than the Nasdaq Composite over the past year, reinforcing analysts’ moderate optimism regarding the stock’s forward outlook.

Barchart · Dec 16, 2025

Up Over 20% in 2025, These 3 Stocks Are Boosting Buyback Capacity

Check out these three stocks that are up more than 20% in 2025 and just increased their buyback capacity. One stock experiencing strong growth stands out.

MarketBeat · Dec 1, 2025

Solventum Stock: Analyst Estimates & Ratings

Solventum has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Barchart · Nov 13, 2025

What to Expect From Solventum's Next Quarterly Earnings Report

Solventum will release its third-quarter earnings next month, and analysts anticipate a double-digit bottom-line growth.

Barchart · Oct 24, 2025

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga · Oct 7, 2025

Zeta Network Leverages SOLV Platform To Boost Bitcoin Treasury And Staking

Zeta Network Group (NASDAQ:ZNB) said Tuesday it has entered into a strategic partnership with SOLV Foundation, a multi-chain Bitcoin liquid staking and structured finance platform with $2.5 billion in total value locked, to strengthen its position as a Bitcoin-focused digital asset finance company.

Barchart · Sep 24, 2025

Is Solventum Stock Underperforming the S&P 500?

While Solventum has underperformed the S&P 500 recently, analysts remain moderately optimistic about the stock’s prospects.

Evening Standard · Aug 21, 2025

What can laughing gas do to your body? 6 tonnes of nitrous oxide canisters cleaned up from Notting Hill Carnival 2024

What is laughing gas, why is it dangerous, and if you’re doing it, how can you maximise your safety?

Barchart · Aug 18, 2025

Do Wall Street Analysts Like Solventum Stock?

Although Solventum has outperformed the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart · Jul 24, 2025

What to Expect From Solventum's Q2 2025 Earnings Report

Solventum will release its second-quarter earnings next month, and analysts anticipate a single-digit profit dip.

Barchart · Jun 25, 2025

How Is Solventum's Stock Performance Compared to Other Health Care Equipment Stocks?

Solventum has outperformed relative to its healthcare equipment peers over the past year, but Wall Street analysts maintain a skeptical view on the stock’s outlook.

Barchart · May 16, 2025

Solventum Stock Outlook: Is Wall Street Bullish or Bearish?

Solventum has outperformed the broader market over the past year, yet analysts remain cautious about the stock’s prospects.

Barchart · Apr 28, 2025

Here's What to Expect From Solventum’s Next Earnings Report

Solventum is expected to unveil its first quarter results in the upcoming month, and analysts predict its bottom line to suffer in double digits.

Barchart · Apr 2, 2025

Solventum Stock: Is SOLV Outperforming the Healthcare Sector?

Despite outpacing the healthcare sector over the past year, analysts remain cautious about the stock’s prospects.

Barchart · Feb 17, 2025

Are Wall Street Analysts Predicting Solventum Stock Will Climb or Sink?

Although Solventum has outperformed the broader market over the past year, Wall Street analysts remain cautious about the stock's growth potential.

Barchart · Jan 20, 2025

Earnings Preview: What to Expect from Solventum’s Report

Recently spun-off healthcare major Solventum is expected to announce its fourth-quarter results in the upcoming month and analysts predict an EPS of $1.31.

1 2

Coverage From

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

United States

424,194 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.